All Stories

Skinbiotherapeutics: AGM dissembling, the words of the QCA twisted by Stuart Ashman

Tom Winnifrith
Thursday 18 December 2025
Skinbiotherapeutics (SBTX) has today confirmed that it is still on track to meet broker forecasts which it confirmed it was on track to meet with results on December 5. Wow: 13 days without a profits warning, give Stuart Ashman a bonus. What a prick. But then it turns to the AGM where it says it has posted a Q&A in response to some shareholder questions. It dissembles.

on Tom Winnifrith | Comments
About Tom Winnifrith
Bio
Tom Winnifrith is the editor of TomWinnifrith.com. When he is not harvesting olives in Greece, he is (planning to) raise goats in Wales.
Twitter
@TomWinnifrith
Email
[email protected]
Recently Featured on ShareProphets
Sign up for my weekly newsletter








Required Reading

Recent Comments


I also read